Thus, it is reasonable to speculate that the excessive accumulation of bile acids and sphingolipids in HBV-associated HCC patients triggers lipid metabolism reprogramming via the activation of the MAPK/mTOR pathway in HCC cells. Here, MTOR is linked to hepatocellular carcinoma.